机译:探讨患者观察患者膀胱癌膀胱镜检测尿生物标志物试验可接受性的混合方法
Division of Surgery and Interventional ScienceUniversity College LondonLondon UK;
Department of Primary Care MedicineUniversity of MalayaKuala Lumpur Malaysia;
Department of Primary Care MedicineUniversity of MalayaKuala Lumpur Malaysia;
Health Behaviour Research CentreUniversity College LondonLondon UK;
Division of Surgery and Interventional ScienceUniversity College LondonLondon UK;
Surgical and Interventional Trials UnitUniversity College LondonLondon UK;
Division of Surgery and Interventional ScienceUniversity College LondonLondon UK;
Surgical and Interventional Trials UnitUniversity College LondonLondon UK;
Surgical and Interventional Trials UnitUniversity College LondonLondon UK;
Department of Primary Care MedicineUniversity of MalayaKuala Lumpur Malaysia;
Division of Surgery and Interventional ScienceUniversity College LondonLondon UK;
biomarker; diagnostic; patient‐reported outcome measure; questionnaires; semi‐structured interviews; BladderCancer; blcsm;
机译:探讨患者观察患者膀胱癌膀胱镜检测尿生物标志物试验可接受性的混合方法
机译:尿液生物标志物在膀胱癌监测中的应用:患者观点。
机译:探索患者的经验和膀胱癌诊断的感知:混合方法方法
机译:使用最佳生物标志物方法从T2加权MR图像进行膀胱癌T分期
机译:膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
机译:混合方法探讨患者对尿液生物标志物测试在替代膀胱镜检查以监测膀胱癌中可接受性的观点
机译:探讨患者观察患者膀胱癌膀胱镜检测尿生物标志物试验可接受性的混合方法